MYGN

#2609
Myriad Genetics Inc
4.6100
-2.91%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
4.6100
4.6100
Jahresspanne
4.1050
8.5000
Tagesänderung
-2.91%
Monatliche Änderung
-22.52%
6 month change
-44.26%
Jahresänderung
-44.26%
Vorheriger Schlusskurs
4.7483
Open
4.6100
Bid
Ask
Low
4.6100
High
4.6100
Volumen
97
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 426.886 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.56
Price to sales ratio
0.69
Dividends per share
—
Dividend yield %
—

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Nachrichten